Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...

With another JP Morgan in the rearview mirror ... Andrew Obershain, CEO of bluebird bio, said as much on stage. A year before the FDA approved his company’s gene therapy for sickle cell ...

An Invitation to Tesla's Colorado Springs," takes readers through a day in the life of the famous Serbian-American inventor who lived in the Springs for eight months from 1899-1900. Rather than a ...

J.P. Morgan Asset Management is enhancing its real estate business with the appointment of Chad Tredway as Global Head of ...

Roy Issa, Vice President and Banker, J.P. Morgan Private Bank -- Roy Issa has joined J.P. Morgan Private Bank in Baton Rouge ...

J.P. Morgan Asset Management is bowing out of its ownership stake of a prominent Washington, D.C.-based development firm, and is taking some of the company’s buildings as part of the exit deal. Alony ...

May 16, 2025. More for You ...

May 16, 2025. More for You ...

PORTLAND, Ore., May 12, 2025 /PRNewswire/ -- Campbell Global, a leader in forestland investing and management, and a vital part of J.P. Morgan Asset Management's $400 billion alternatives business ...

announced today that it will participate in the JP Morgan 53 rd Annual Technology, Media & Communications Conference on Wednesday, May 14, 2025. The conference will include a fireside chat with ...

Tensor9 helps software vendors unlock new customers that can't outsource their data to a third-party software vendor.